CARDIOVASCULAR CORELATIONS IN CHILDREN WITH END STAGE RENAL DISEASE

Slides:



Advertisements
Similar presentations
Cardiovascular Disease In CKD: Is It for Children
Advertisements

Nuevas Soluciones en DP, Sirven? Prueba en diabéticos con transporte peritoneal alto y promedio alto Dr. José Ramón Paniagua Sierra Unidad de Investigación.
Uncontrolled secondary hyperparathyroidism in a haemodialysis patient Jordi Bover, MD, PhD Fundació Puigvert Barcelona, Spain © Springer Healthcare, a.
Predictors of Early Cardiovascular Disease in Children with CKD
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.
Current European guidelines for management of arterial hypertension: Are they adequate for use in primary care? Halfdan Petursson Linn Getz Johann Agust.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
1 Adult Hemodialysis Longitudinal Follow-Up Data 2002–2008.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Consensus procedure for the management of children with ESRD.
Comparison of Asymmetric DimethylArginine Levels and Coronary Artery Calcifications in Different Stages of Chronic Kidney Disease and Kidney Transplantation.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Long Term Peritoneal Dialysis In Children – Frequent Complications Conclusions: Peritoneal Dialysis is the method of choice for pediatric patients, with.
RELATIONSHIP BETWEEN PARATHYROID HORMONE, VITAMIN-D, CALCIUM AND PHOSPHORUS IN CKD Neeraja Kunireddy, Priscilla Abraham Chandran, Sree Bhushan Raju, M.Noorjahan.
Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease Department of Nephrology R3. Yeehyung Kim.
Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Obesity Hypertension and Endothelial Dysfunction in Pediatric Patients
A.M. Thompson, T.G. Pickering  Kidney International 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
LDL cholesterol in CKD—to treat or not to treat?
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.
Intensive Hemodialysis: Applied Clinical Practice
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
The IDEAL Study Reference
Independent Samples Test Independent Samples Test
HEIGHT-AGE-SEX SPECIFIC BODY MASS INDEX IN CHILDREN WITH END STAGE RENAL DISEASE - SINGLE CENTER EXPERIENCE 1 Fundeni Clinical Institute, Bucharest, Romania.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Volume 67, Pages S1-S7 (June 2005)
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.
Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,
Laboratory November 2017 End stage renal disease.
Laboratory 9- Week of November 2015
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 79, Issue 9, Pages (May 2011)
Arterial stiffness and pulse pressure in CKD and ESRD
A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Section 5: Configuration of healthcare to manage CKD
I. Introduction American Journal of Kidney Diseases
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Volume 88, Issue 2, Pages (August 2015)
Meeting the challenges of the new K/DOQI guidelines
Volume 79, Pages S9-S13 (April 2011)
Volume 76, Pages S50-S99 (August 2009)
Homocysteine and risk in end-stage renal disease: a matter of context
Volume 76, Issue 10, Pages (November 2009)
Volume 84, Issue 5, Pages (November 2013)
LDL cholesterol in CKD—to treat or not to treat?
Blood pressure targets in hemodialysis patients
Cardiovascular complications in chronic kidney disease
Volume 87, Issue 1, Pages (January 2015)
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 70, Issue 6, Pages (September 2006)
Volume 70, Issue 3, Pages (August 2006)
Volume 64, Issue 2, Pages (August 2003)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Pathophysiology of cardiovascular disease in hemodialysis patients
Volume 75, Issue 1, Pages (January 2009)
Recent developments in the management of secondary hyperparathyroidism
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Authors’ concept of aortic stiffness in relation to other cardiovascular risk factors. Authors’ concept of aortic stiffness in relation to other cardiovascular.
Attributable risk for disorders of mineral metabolism.
Presentation transcript:

CARDIOVASCULAR CORELATIONS IN CHILDREN WITH END STAGE RENAL DISEASE AUTHORS Adrian C. Lungu Alexandra Niculae Fundeni Clinical Institute, Bucharest, Romania – Pediatric Dialysis and Nephrology Department Carol Davila Bucharest University of Medicine Cristina Orlov Cristina Stoica INTRODUCTION Cardiovascular involvement remains one of the leading causes of morbidity and mortality in children with Chronic Kidney Disease on Renal Replacement Therapy. Left ventricular hypertrophy, aortic calcifications, arterial stiffness and hypertension have been recognized as risk factors for sudden death in pediatric patients with end-stage renal disease. This study is designed to assess the relationship between the End Stage Renal Disease risk factors and cardiovascular events. Methods: This is a single center, 2 years, prospective study including 20 subjects with End Stage Renal Disease. We analyzed the plasmatic level of hemoglobin, calcium, phosphate, intact- parathyroid hormone (i-PTH), cholesterol, triglycerides, C reactive protein (CRP), serum creatinine and urea levels. Cardiovascular parameters measured were: Fluid overload, Blood Pressure, Cardiac Frequency, Left Ventricular Mass, Diastolic Dysfunction, Intima-Media Thickness. Fluid overload was clinically assessed. Results: All the patients included in our study had high levels of i-PTH, with secondary increase of calcium and phosphate serum levels. 45% of boys and 40% of girls presented Left Ventricular Hypertrophy, which was correlated with a high Systolic Blood Pressure, and volume overload, but not with the period of time on renal replacement therapy. Diastolic Dysfunction witch was determined as E/A waves fraction was correlated with urea levels, Systolic Blood Pressure values and volume overload. Cardiac frequency had a positive correlation with the volume overload and a negative one with Hemoglobin levels. Intima-Media Thickness had a direct positive correlation with i-PTH, calcium - phosphorous levels and product and high Systolic Blood Pressure . Dyslipidemia was not associated with arterial thickness in children with ESRD, which is an important difference as compared to adults with CKD and CVD Left Ventricular Mass Systolic BP Volemic overload (L) Dialysis Vintage (month) Dialysis vintage positively correlats with left ventricular mass. The volemic overload is an important factor influencing the blood pressure and Left Ventricular Mass iPTH values Intima-media thickness Positive linear correlation between iPTH values and (Intima-media thickness) IMT Ca, P values (mg/dl) CRP Intima-media thickness Intima-media thickness Intima-Media Thickness had a direct positive correlation with i-PTH, calcium - phosphorous levels and product and high Systolic Blood Pressure Conclusions: Left Ventricular Mass is directly related to the degree of systolic blood pressure and the volume overload, but does associate Diastolic Dysfunction only in a small number of patients. Intima-Media Thickening is the result of volume overload, increased calcium-phosphorous product, but not of the inflammatory status measured by serum C-reactive protein. Drastic reduction of volume overload in children on peritoneal dialysis and hemodialysis, the reduction of serum calcium and phosphorous levels and the correct treatment of hypertension are the most important targets for a patient with End Stage Renal Disease E/A (Diastolic Dysfunction) intervals Uree (mg/dl) E/A waves fraction was correlated with urea levels, Systolic Blood Pressure values and volume overload. Cardiac frequency had a positive correlation with the volume overload and a negative one with Hemoglobin levels AKNOWLEDGEMENT: This paper is supported by the Sectorial Operational Programme in Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the contract number POSDRU/159/1.5/s/137390/ Contact: Dr. Adrian Lungu +40722131950, adilungu@mediakompass.ro